Flurotech Awarded Best Of Show For New Technology By High! Canada Magazine At The Vancouver Lift Expo

We are pleased to announce that the CompleTest™ was selected as our best of show for new cannabis technology by our High! Canada Magazine at the recent Vancouver LIFT Expo (High! Canada’s Article).

“The award was unexpected,” commented Gary Jones VP of Business Development at FluroTech. “The Vancouver LIFT Expo was the first time FluroTech unveiled the CompleTest™ to the public. Master growers and quality assurance personnel were impressed by the live demos as it demonstrated the confidence the Company has in the technology. Feedback was positive with respect of with the simplicity, speed, accuracy, and consistency of results of the product. Master growers recognized that they could affordably and accurately use the in-house testing device to select mother plants for breeding or to optimize their potency yield for a given strain.”

The Company believes that a fast, reliable, accurate and easy-to-use in-house testing device is required in the cannabis industry so that growers can focus on precision agriculture and optimize the potency yield of their crop without waiting for quality assurance personnel or third-party lab results. Moreover, licensed producers will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.

“The CompleTest™ stood out amongst the other new technologies at the Vancouver LIFT Expo,” stated Cy Williams Publisher and Editor at High! Canada Magazine. “Growing cannabis, especially premium product, is a science; however, historically growers have relied on experience and physical appearance of plants or trichomes to select mother plants for breeding and production purposes. With the CompleTest™ growers are able to affordably generate the scientific data to select mother plants or croptimize a cannabis strains potency yield.”

The Company has launched sales and is focusing its sales efforts in Western Canada.

About High! Canada Magazine

For over 4 years High! Canada Magazine has been delivering a diverse mix of marketing campaigns that continue to zero in on key industry decision makers. Our title publication High! Canada Magazine offers targeted specialized circulation that allows us to pin point advertising messages directly to trade specific readers. High! Canada was recently awarded one of Canada’s Top 20 Magazines.

About CompleTest™

CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and consumer safety to test the quality and safety of their cannabis products.

About FluroTech (TSX-V: TEST) (OTCQB: FLURF)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com

Contact Information:

Gary Jones

VP Business Development

403.650.9277

gpjones@flurotech.com

Danny Dalla-Longa

Chief Executive Officer

403.680.0644

danny@flurotech.com

FluroTech Ltd.

Alistair Ross Technology Centre

Suite 111, 3553-31 Street NW

Calgary, AB T2L 2K7

info@flurotech.com

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the benefits of the Company’s CompleTest™ testing device.

The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis industry in general, and users of the CompleTest™ failing to achieve the anticipated benefits of the product. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.

The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.